Eisai Submits Application for Additional Indication of Anti-arrhythmic Agent Tambocor(R) Tablets for Tachyarrhythmia in

  Tokyo, Jan 14, 2010 - (JCN Newswire) - Eisai Co., Ltd. announced today that the Company has submitted an application for approval of an additional indication of anti-arrhythmic agent Tambocor(R) 50mg Tablets and Tambocor(R) 100mg Tablets (generic name: flecainide acetate) for the treatment of tachyarrhythmia (paroxysmal atrial fibrillation/flutter, paroxysmal supraventricular tachycardia, ventricular tachycardia) in paediatric patients in Japan.  

Sydney

  [ Change ]
 
Today

Max: 19°
Shower or two.
Tomorrow

Min: 13°
Max: 20°
Possible shower.
 

Account

Login

To access your account and listings



Remember me
   
   
   
 
 
Find Hunter Valley accommodation online